VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer.
about
Modification in the diet can induce beneficial effects against breast cancerFrom promotion to management: the wide impact of bacteria on cancer and its treatmentAnalysis of changes in diversity and abundance of the microbial community in a cystic fibrosis patient over a multiyear periodThe gut microbiota in mouse models of inflammatory bowel disease.Emerging science of the human microbiome.[Interaction between humans and intestinal bacteria as a determinant for intestinal health : intestinal microbiome and inflammatory bowel diseases].High throughput sequencing reveals distinct microbial populations within the mucosal and luminal niches in healthy individuals.Effects of Lactobacillus salivarius Ren on cancer prevention and intestinal microbiota in 1, 2-dimethylhydrazine-induced rat model.Differential Metabolism of Exopolysaccharides from Probiotic Lactobacilli by the Human Gut Symbiont Bacteroides thetaiotaomicronMicrobiome and metabolome modifying effects of several cardiovascular disease interventions in apo-E-/- mice.Anti-tumour immune effect of oral administration of Lactobacillus plantarum to CT26 tumour-bearing mice.Probiotics, gut microbiota, and their influence on host health and disease.Aggregation factor as an inhibitor of bacterial binding to gut mucosa.Carcinogenesis and therapeutics: the microbiota perspective.The gut microbiome and liver cancer: mechanisms and clinical translation.Probiotic strains and mechanistic insights for the treatment of type 2 diabetes.Randomized, controlled trial evaluating the effect of multi-strain probiotic on the mucosal microbiota in canine idiopathic inflammatory bowel disease.Alterations of Enteric Microbiota in Patients with a Normal Ileal Pouch Are Predictive of Pouchitis.Pretreatment with probiotic Bifico ameliorates colitis-associated cancer in mice: Transcriptome and gut flora profiling.Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3.Inhibition of chronic ulcerative colitis-associated adenocarcinoma development in mice by VSL#3.Probiotic supplementation and associated infant gut microbiome and health: a cautionary retrospective clinical comparison.Lactobacilli with superoxide dismutase-like or catalase activity are more effective in alleviating inflammation in an inflammatory bowel disease mouse model
P2860
Q26861193-E7DC1423-13BC-4995-87D6-D1D0D0B6A440Q34263890-E76D9694-FA5F-4DC2-AEB1-F9019572E665Q34916610-463EB4BC-D6D2-407F-91D3-606E5B6792DFQ35117031-796EFEAF-BD72-4A7D-A7DB-B42530A4D4BFQ35205214-8E691ED5-426F-4AB1-A5A3-DF4559E63FD5Q35539435-AE93BF43-3B04-4333-94FF-A328976C2BC7Q35615264-6833B946-F3B2-45D1-A793-1500D26F5F66Q35646615-35971FF9-9D94-40C9-BE42-7991BE3F1311Q35914087-5A225E42-06B9-45E8-8704-9801444BFC5DQ37695020-24D26C2E-F4B0-46C0-BF3A-E4BB6598C5C8Q38876416-5C07F368-8CAE-4EEE-9FF7-74358D3B6389Q38921638-24B82F04-AB5A-40CF-B1AB-8FFE7DDE41BCQ38995465-9F12D3D7-DEED-4FC7-A093-2C1F2AECABEBQ39146396-C1B2D54A-E791-4582-A544-4563EE057BCEQ39414187-40626BD5-F951-4679-A043-1162875DAD6DQ46279792-66A0912C-B4BF-408C-9706-E63AAEEAB9DAQ46340421-81E24FFA-1B45-40F5-BA9E-4C24374B4914Q46491513-107F5B71-1CD3-433D-9C44-BB80AFC70E10Q49483670-F085391F-2339-4526-86BD-22FC5774B7D5Q52892251-565B0876-0BB4-4D9D-9305-A7958F66FA37Q53575927-3997D8C0-0BEF-4DBF-8D03-CBBA67BDCCFEQ54958970-41C305F5-5634-4A8E-BA26-E219B3480671Q57490013-EC229564-8CD9-4EC7-9947-A11B3234D565
P2860
VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
VSL#3 probiotic modifies mucos ...... -associated colorectal cancer.
@ast
VSL#3 probiotic modifies mucos ...... -associated colorectal cancer.
@en
type
label
VSL#3 probiotic modifies mucos ...... -associated colorectal cancer.
@ast
VSL#3 probiotic modifies mucos ...... -associated colorectal cancer.
@en
prefLabel
VSL#3 probiotic modifies mucos ...... -associated colorectal cancer.
@ast
VSL#3 probiotic modifies mucos ...... -associated colorectal cancer.
@en
P2093
P2860
P356
P1433
P1476
VSL#3 probiotic modifies mucos ...... -associated colorectal cancer.
@en
P2093
Anthony A Fodor
Christian Jobin
Ernesto Perez-Chanona
Joshua M Uronis
Marcus Mühlbauer
Raad Z Gharaibeh
P2860
P2888
P356
10.1038/SREP02868
P407
P577
2013-10-08T00:00:00Z